E. Eigendorff

1.8k citations
11 papers · 755 · 1 hit paper · h-index 7

Impact in

Papers in

E. Eigendorff

11 papers receiving 750 citations

E. Eigendorff's Hit Papers

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer 2023 · 510 citations
5100+1+2Years since publication100200300400500

Peers

E. Eigendorff
Comparison fields: 5 of 56
  • Pulmonary and Respiratory Medicine 368
  • Oncology 264
  • Endocrinology, Diabetes and Metabolism 94
  • Behavioral Neuroscience 12
  • Cancer Research 42
Replace Guillermo Alonso with:
Guillermo Alonso Spain
Dongbao Li China
Louis‐Joseph Auguste United States
Jiwang Liang China
Bruce Keith United States
Sarah Yentz United States
N. Panza Italy
Takashi Kizu Japan
Young Sun Lee United States
R. Nagel Germany
E. Eigendorff relative to Guillermo Alonso Spain Guillermo Alonso's profile →
Citations per field
00.5×12×
Guillermo Alonso · 1×
Citations per year

Countries citing papers authored by E. Eigendorff

Since Specialization
Citations

This map shows the geographic impact of E. Eigendorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Eigendorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Eigendorff more than expected).

Fields of papers citing papers by E. Eigendorff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Eigendorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Eigendorff. The network helps show where E. Eigendorff may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Eigendorff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Eigendorff Line = papers co-authored together E. Eigendorff links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Hit paper breakdown →
2023510
2 2002124
3 202351
4 200421
5 202018
6 202311
7 20038
8 20245
9 20104
10 20242
11 20161

About E. Eigendorff

E. Eigendorff is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism, Surgery and Genetics, having authored 11 papers that have together received 755 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Hormonal Regulation and Hypertension (4 papers), Estrogen and related hormone effects (2 papers), Cancer Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Adrenal Hormones and Disorders (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (368 citations), Oncology (264 citations), Endocrinology, Diabetes and Metabolism (94 citations), Behavioral Neuroscience (12 citations) and Cancer Research (42 citations). E. Eigendorff has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Heather A. Wakelee, Jamie E. Chaft, Gastón Lucas Martinengo, Margarita Majem, Delvys Rodríguez‐Abreu, Terufumi Kato, Ayman Samkari, Olivier Bylicki, Christophe Dooms and Moïshe Liberman. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Hormone and Metabolic Research, New England Journal of Medicine and Journal of Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact